Abstract
Alternative cleavage of the amyloid precursor protein (APP) results in generation and secretion of both soluble APP (sAPP) and beta-amyloid (Abeta). Abeta is the main component of the amyloid depositions in the brains of Alzheimer's disease (AD) patients. Using Western blotting, we compared the levels of alpha-secretase cleaved sAPP, beta-secretase cleaved sAPP and total sAPP, in cerebrospinal fluid (CSF) from 13 sporadic AD patients and 13 healthy controls. Our findings show significant amounts of beta-secretase cleaved sAPP in CSF. There was no statistically significant difference in the levels of beta-secretase cleaved sAPP between AD patients and controls. The levels of alpha-secretase cleaved sAPP and total sAPP were, however, found to be significantly lower in the AD patients than in the controls.
| Original language | English |
|---|---|
| Journal | Neuroscience Letters |
| Volume | 278 |
| Issue number | 3 |
| Pages (from-to) | 169-72 |
| Number of pages | 4 |
| ISSN | 0304-3940 |
| Publication status | Published - 14 Jan 2000 |
| Externally published | Yes |
Keywords
- Aged
- Alzheimer Disease
- Amyloid Precursor Protein Secretases
- Amyloid beta-Protein Precursor
- Aspartic Acid Endopeptidases
- Blotting, Western
- Endopeptidases
- Female
- Humans
- Journal Article
- Male
- Middle Aged
- Reference Values
- Research Support, Non-U.S. Gov't
Fingerprint
Dive into the research topics of 'Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver